SRRK — Scholar Rock Holding Corp catalysts
Next verified catalyst
2026-11-01 — Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Tri · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-01 in 4mo
ESTIMATED |
READOUT
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Pr
Phase 3 · Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3 |
SRRK Scholar Rock Holding Corp | Apitegromab |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|